Barsky, Arthur J.
Silbersweig, David A.
Funding for this research was provided by:
Brigham and Women's Hospital
Article History
Received: 6 April 2022
Accepted: 7 June 2022
First Online: 12 July 2022
Declarations
:
: Dr. Barsky received consulting fees from Leidos Corp., and royalty payments from McGraw Hill Publishers and from Mass General Brigham Inc. He is an equity owner in Buoyant Health. There is no overlap the work in this article. Dr. Silbersweig is co-founder and chair of the SAB of Ceretype Neuromedicine, and has equity in Buoyant health. He receives honoraria for grand rounds, and royalties from McGraw-Hill and American Psychiatric Press. There is no overlap with the work in this article.
Free to read: This content has been made available to all.